Other research analysts also recently issued research reports about the stock. Shore Capital reaffirmed a buy rating on shares of Barclays in a research note on Thursday, August 2nd. Goldman Sachs Group set a GBX 220 ($2.87) price objective on shares of Barclays and gave the company a neutral rating in a research note on Monday, July 23rd. Royal Bank of Canada reaffirmed a sector performer rating and set a GBX 220 ($2.87) price objective on shares of Barclays in a research note on Wednesday. Deutsche Bank reaffirmed a buy rating and set a GBX 239 ($3.12) price objective (up previously from GBX 236 ($3.08)) on shares of Barclays in a research note on Friday, August 3rd. Finally, Credit Suisse Group set a GBX 235 ($3.07) price objective on shares of Barclays and gave the company a buy rating in a research note on Thursday, July 19th. One research analyst has rated the stock with a sell rating, four have given a hold rating and thirteen have given a buy rating to the company’s stock. The company presently has an average rating of Buy and an average price target of GBX 228.56 ($2.99).
LON BARC opened at GBX 168.06 ($2.20) on Thursday. Barclays has a 12 month low of GBX 177.30 ($2.32) and a 12 month high of GBX 235.35 ($3.08).
Barclays PLC, through its subsidiaries, provides various financial products and services in the United Kingdom, other European countries, the Americas, Africa, the Middle East, and Asia. The company operates through Barclays UK and Barclays International divisions. It offers personal and business banking services; credit and debit cards; international banking; and private banking services, which include investment, wealth planning, and credit and specialist solutions to high net worth and ultra-high net worth clients, and family offices.
Further Reading: Marijuana Stocks Investing Considerations
Receive News & Ratings for Barclays Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Barclays and related companies with MarketBeat.com's FREE daily email newsletter.